Less Ads, More Data, More Tools Register for FREE

Pin to quick picksWPP Regulatory News (WPP)

Share Price Information for WPP (WPP)

Share Price is delayed by 15 minutes
Get Live Data
276.70    5.40 (1.99%)
Bid:
276.50
Ask:
276.90
Spread: 0.40 (0.145%)
Market Cap: £2.98b
WPP Live PriceLast checked at - London Stock Exchange

Intraday WPP Share Chart

Acquisition

7 Mar 2023 07:00

RNS Number : 0561S
WPP PLC
07 March 2023
 

 

FOR IMMEDIATE RELEASE

7 March 2023

 

WPP PLC ("WPP")

 

WPP acquires German healthcare specialist 3K Communication

 

Frankfurt-based 3K will join WPP's Hill+Knowlton Strategies, advancing the company's growth in the global healthcare sector

 

WPP announces today that it has acquired 3K Agentur für Kommunikation (3K), one of the leading healthcare specialist PR agencies in Germany. 3K will become part of the Hill+Knowlton Strategies (H+K) global network, strengthening its healthcare presence in Europe and expanding its operations in Germany.

Founded 25 years ago, 3K is known for its expertise in healthcare, biopharmaceuticals, and related sciences, working with some of the world's most notable global pharmaceutical companies, consumer health brands, and local biotech start-ups.

The addition of 3K aligns with WPP's strategic focus on healthcare and marks the company's continued investment in Germany. In the second half of 2022, WPP appointed Wendy Lund as Chief Client Officer for Health & Wellness and FM Schmidt as WPP's first President of the German market. 

The acquisition is also the latest milestone in H+K's ongoing transformation. The agency has grown more than 25% over the last two years, expanding its global leadership team - including Brenna Terry as Global Chair of Healthcare - and acquiring the JeffreyGroup in Latin America.

AnnaMaria DeSalva, Global Chairman and CEO of Hill+Knowlton Strategies, said: "Healthcare is in a perpetual cycle of growth and transformation, demanding superior communication and stakeholder strategies. Hill+Knowlton has a large role to play in this dynamic market. The addition of 3K will meaningfully strengthen our international capability in healthcare, and I am delighted to welcome them to the H+K family."

Ruth Bastuck, Founder and Managing Director of 3K, said: "I'm incredibly proud of what we have successfully built at 3K over the past 25 years, but I am equally excited for our future with Hill+Knowlton. Healthcare is such an important component of H+K's global strategy, and we could not have found a better fit, culturally, strategically, or operationally. We are equally dedicated to shaping excellent medical-to-human interactions. Tapping into the diverse resources and global reach of the H+K and WPP networks will create many exciting new opportunities for both our clients and our employees."

Mark Read, CEO of WPP, said: "Amid today's dynamic macroeconomic conditions we have seen great resilience and growth in the healthcare sector, as well as across our own PR businesses. Germany is our third largest market, and the addition of 3K to Hill+Knowlton's growing portfolio further strengthens WPP's global healthcare offer to clients."

3K becomes the latest in a series of acquisitions - including Fēnom Digital, Diff, Passport, Newcraft and Corebiz in the last six months alone - that form part of WPP's accelerated growth strategy and focused M&A approach to continue to build on the company's core capabilities.

 

ENDS

 

Further information:

Louise Lacourarie, WPP

+44 (0)20 7282 4600 / +44 7741 360931

louise.lacourarie@wpp.com

 

Sarah Brandon, Hill+Knowlton

+1 416 413 4773

sarah.brandon@hkstrategies.com

 

About WPP WPP is the creative transformation company. We use the power of creativity to build better futures for our people, planet, clients and communities. For more information, visit www.wpp.com.

 

About Hill+Knowlton

Hill+Knowlton Strategies, Inc. is an international communications consultancy, providing services to local, multinational, and global clients. H+K operates more than 70 offices in nearly 40 countries worldwide, as well as an extensive associate network, delivering award-winning campaigns to clients across all sectors and disciplines and with a focus on continued innovation for the industry. Headquartered in New York, the firm is part of WPP, one of the world's largest communications services groups. For more information about H+K, click here, follow us on Twitter here, like us on Facebook here, and follow us on LinkedIn here.

 

About 3K

Founded in 1998, 3K is one of the leading healthcare PR agencies in Germany, helping clients translate complex issues in healthcare and science into innovative formats, bringing products, brands and companies into the conversation. http://www.3k-kommunikation.de/

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ACQEAKDKELKDEFA
Date   Source Headline
22nd Oct 20242:26 pmRNSNotification of Major Holdings
18th Oct 20243:34 pmRNSNotification of Major Holdings
17th Oct 202410:40 amRNSNotification of Major Holdings
10th Oct 20249:59 amRNSNotification of Major Holdings
1st Oct 20243:37 pmRNSTotal Voting Rights and Capital
26th Sep 20243:35 pmRNSNotification of Trading Update
24th Sep 20241:23 pmRNSNotification of Major Holdings
23rd Sep 20244:37 pmRNSNotification of Major Holdings
10th Sep 202412:00 pmRNSAcquisition
2nd Sep 20245:04 pmRNSTotal Voting Rights and Capital
7th Aug 20247:00 amRNSWPP to sell its majority stake in FGS Global
7th Aug 20247:00 amRNS2024 Interim Results
1st Aug 202411:41 amRNSTotal Voting Rights and Capital
30th Jul 20247:00 amRNSBoard Appointment
1st Jul 202412:32 pmRNSTotal Voting Rights and Capital
27th Jun 20244:21 pmRNSNotification of 2024 Interim Results
4th Jun 20244:36 pmRNSNotification of Major Holdings
3rd Jun 202412:01 pmRNSTotal Voting Rights and Capital
9th May 20245:25 pmRNSExecutive Share Awards
8th May 20243:30 pmRNSResults of AGM
2nd May 20249:18 amRNSNotification of Major Holdings
1st May 20242:40 pmRNSTotal Voting Rights and Capital
25th Apr 202412:55 pmRNSNotification of Major Holdings
25th Apr 20247:00 amRNSFirst Quarter Trading Update
2nd Apr 20241:45 pmRNSTotal Voting Rights and Capital
21st Mar 20245:00 pmRNSAnnual Report 2023 on Form 20-F
21st Mar 20244:19 pmRNSAnnual Report 2023 and AGM Notice
21st Mar 20241:19 pmRNSNotification of Trading Update
18th Mar 20244:31 pmRNSVesting of executive share award
13th Mar 20245:10 pmRNSExecutive Performance Share Awards
13th Mar 20245:10 pmRNSVesting of executive share awards
1st Mar 202411:08 amRNSTotal Voting Rights and Capital
27th Feb 20246:08 pmRNSNotification of Major Holdings
22nd Feb 20247:00 amRNS2023 Preliminary Results
8th Feb 20248:00 amRNSInvestment
7th Feb 202410:29 amRNSNotification of Major Holdings
1st Feb 202412:42 pmRNSTotal Voting Rights and Capital
30th Jan 20247:00 amRNSCapital Markets Day 2024
12th Jan 202412:45 pmRNSNotification of CMD and 2023 Preliminary Results
2nd Jan 20243:03 pmRNSTotal Voting Rights and Capital
11th Dec 20234:38 pmRNSDirector / PDMR Transaction notification
11th Dec 20233:02 pmRNSNotification of Major Holdings
8th Dec 202311:47 amRNSExecutive Share Awards
1st Dec 20235:04 pmRNSTotal Voting Rights and Capital
21st Nov 20231:05 pmRNSAcquisition
16th Nov 20233:23 pmRNSDIRECTOR / PDMR TRANSACTION NOTIFICATION
1st Nov 20232:17 pmRNSTotal Voting Rights and Capital
26th Oct 20237:00 amRNSThird Quarter Trading Update
10th Oct 20234:59 pmRNSNotification of Trading Update
2nd Oct 202311:58 amRNSTotal Voting Rights and Capital

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.